全文获取类型
收费全文 | 6821篇 |
免费 | 398篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 109篇 |
妇产科学 | 168篇 |
基础医学 | 1285篇 |
口腔科学 | 177篇 |
临床医学 | 591篇 |
内科学 | 1131篇 |
皮肤病学 | 136篇 |
神经病学 | 590篇 |
特种医学 | 246篇 |
外国民族医学 | 1篇 |
外科学 | 755篇 |
综合类 | 24篇 |
预防医学 | 770篇 |
眼科学 | 121篇 |
药学 | 612篇 |
中国医学 | 10篇 |
肿瘤学 | 470篇 |
出版年
2022年 | 53篇 |
2021年 | 131篇 |
2020年 | 78篇 |
2019年 | 114篇 |
2018年 | 144篇 |
2017年 | 110篇 |
2016年 | 127篇 |
2015年 | 150篇 |
2014年 | 209篇 |
2013年 | 327篇 |
2012年 | 420篇 |
2011年 | 456篇 |
2010年 | 309篇 |
2009年 | 173篇 |
2008年 | 256篇 |
2007年 | 256篇 |
2006年 | 205篇 |
2005年 | 289篇 |
2004年 | 292篇 |
2003年 | 230篇 |
2002年 | 249篇 |
2001年 | 209篇 |
2000年 | 218篇 |
1999年 | 173篇 |
1998年 | 67篇 |
1997年 | 78篇 |
1996年 | 57篇 |
1995年 | 59篇 |
1992年 | 84篇 |
1991年 | 90篇 |
1990年 | 110篇 |
1989年 | 99篇 |
1988年 | 80篇 |
1987年 | 77篇 |
1986年 | 85篇 |
1985年 | 85篇 |
1984年 | 72篇 |
1983年 | 69篇 |
1982年 | 44篇 |
1981年 | 49篇 |
1980年 | 40篇 |
1979年 | 81篇 |
1978年 | 49篇 |
1977年 | 51篇 |
1976年 | 47篇 |
1974年 | 44篇 |
1973年 | 41篇 |
1972年 | 44篇 |
1971年 | 46篇 |
1969年 | 46篇 |
排序方式: 共有7251条查询结果,搜索用时 46 毫秒
1.
2.
Éktova L. V. Goryunova O. V. Eremina V. A. Tikhonova N. I. Medvedeva L. A. 《Pharmaceutical Chemistry Journal》2019,53(7):604-609
Pharmaceutical Chemistry Journal - Use of formylindolylacetic acid as a reagent at the stage of preparing the glycosides of bis(indolyl)furan-2,5-diones and dioxane as solvent increased yields from... 相似文献
3.
Béla Nagy Zsolt Bene Zsolt Fejes Sonya L. Heltshe David Reid Nicola J. Ronan Yvonne McCarthy Daniel Smith Attila Nagy Elizabeth Joseloff György Balla János Kappelmayer Milan Macek Scott C. Bell Barry J. Plant Margarida D. Amaral István Balogh 《Journal of cystic fibrosis》2019,18(2):271-277
Background
We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.Methods
In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).Results
After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).Conclusions
This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy. 相似文献4.
Duds Eszter Susa va Pamjav Horolma Szabolcsi Zoltn 《International journal of legal medicine》2020,134(2):487-489
International Journal of Legal Medicine - Gyula Ágner was a Royal Hungarian First Lieutenant (1st Lt.) during the World War II and died at 30 years old due to a mine shrapnel injury... 相似文献
5.
6.
7.
Objectives: Published studies of intradiscal thermal annuloplasty (IDTA) have shown at most 50% pain relief as an improved outcome with little focus on functional improvement in the treatment of discogenic pain. Previous studies have used a number of criteria for patient selection including low back pain unresponsive to conservative care, no compressive radiculopathy, positive provocative discography and absence of previous surgery at the same symptomatic level. The purpose of present study is to examine the hypothesis that additional inclusion criteria for patient selection such as disc height, absence of degenerative disc disease (DDD) in untreated discs, absence of herniated nucleus pulposus or lumbar canal stenosis may improve the outcome of treatment. Methods: In this prospective case‐series study additional criteria of patient selection were introduced, namely disc height of at least 50%, no lumbar canal stenosis, one or two levels of DDD, no evidence of nucleus pulposus herniation on magnetic resonance image. Thirty‐four patients were enrolled in the study and 32 of them were followed over a period of 12 months. The visual analog scale (VAS) pain score and seven activities of daily living (ADLs) were followed and reported on a scale from 0 to 10. Results: Sustained decrease of the VAS pain scores was observed from 3 to 12 months following IDTA. ADLs improved in all patients between 3 and 12 months post‐treatment. Patients in the Bureau of Workers Compensation (BWC) group had a higher VAS score but showed the same level of improvement in ADLs as compared to commercial insurance or self‐pay patients. In the non‐BWC patient group an average VAS pain score decrease of more than 6 points on a 10‐point scale was reported at 6 to 12 months following IDTA. Conclusions: We found dramatic improvement of pain scores and ADLs following IDTA when strict patient selection was applied. We believe that IDTA is an effective, minimally invasive treatment for discogenic pain in properly selected patients. 相似文献
8.
股骨干骨折--扩髓和不扩髓髓内钉比较 总被引:4,自引:0,他引:4
JamesF.Kellam LadislavNagy RodrigoF.Pesantez 《中华创伤骨科杂志》2004,6(9):1048-1052
治疗股骨干骨折,采用不扩髓髓内钉比扩髓髓内钉手术时间明显缩短,而且失血也少。但是,扩髓钉的骨愈合更快,延迟愈合更少。两者都没有显著增加包括肺损害等其它并发症的风险。功能结果不能确定。 相似文献
9.
10.
Michael Hutchinson Jonathon O'Riordan Mohammed Javed Etain Quin Donal Macerlaine Teresa Willcox Nollaig Parfrey Tamas G. Nagy Elisabeth Tournier-Lasserve 《Annals of neurology》1995,38(5):817-824
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a recently described familial cerebrovascular disorder shown to map to chromosome 19q12. Familial hemiplegic migraine has also been shown in some families to map close to the CADASIL locus. The fully developed CADASIL phenotype consists of recurrent strokes developing in the fourth decade, progressing to a pseudobulbar palsy, spastic quadriparesis, and subcortical dementia. In an Irish family 15 members were fully investigated by magnetic resonance scanning; 10 had typical magnetic resonance features of CADASIL. Five members of this family had familial hemiplegic migraine and 4 of these had magnetic resonance evidence of CADASIL. Two other members had migraine with and without aura as a presenting clinical symptom of CADASIL. This disorder has been shown by linkage analysis to map to the CADASIL locus at chromosome 19. The phenotype at presentation of CADASIL in this family was variable and age related and included familial hemiplegic migraine, migraine with and without aura, transient ischemic attacks, strokes, and spinal cord infarction. This family study increases our understanding of the spectrum of clinical manifestations of this underrecognized familial cerebrovascular disorder. 相似文献